The company said that with the growing uncertainty surrounding the virus and its near-term financial impacts, Aphria was left with no choice but to rethink its outlook once the pandemic stabilises. That said, an updated guidance may not be provided until the fiscal 2021 year. "Going forward, we believe Aphria continues to be differentiated in the cannabis industry through our brands, cultivation expertise, high quality standards, cash position and balance sheet," Irwin concluded. At the end of February, Aphria had $515.1 million in cash and cash equivalents, which is intended to fund Canadian and international growth. Aphria (APHA) is currently up 4.91 per cent to $5.34 per share at 1:01pm EST.